sur DIAGNOSTIC MEDICAL (EPA:ALDMS)
DMS Group successfully completes its reserved capital increase
DMS Group announced the successful completion of its €6,868,365.049 capital increase with waiver of preferential subscription rights. The transaction, reserved for key investors such as InnoLux Corporation and Bpifrance, resulted in the issuance of 5,798,319 new shares at a unit price of €1.19. All proceeds will be used to support the Imaging 2027 strategic plan and the implementation of the Imaging 2030 plan.
The shares, which will be listed on Euronext Growth Paris starting August 27, 2025, are intended to strengthen the group's presence in Europe and accelerate its growth in the US market. The company also took advantage of this transaction to strengthen its equity without resorting to additional debt.
DMS Group's share capital now stands at €31,570,129.27, divided into 26,651,711 shares, which slightly modifies the initial shareholding structure. This capital increase allows DMS Group to focus its efforts on industrial synergies, the finalization of key products, and the improvement of operating cash flow, while anticipating ambitious development through to 2030.
R. P.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de DIAGNOSTIC MEDICAL